Related Experiment Video
Updated: Apr 17, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Hypertension in minority populations: new guidelines and emerging concepts
Fátima Rodriguez1, Keith C Ferdinand1
1Department of Cardiovascular Medicine, Stanford University, Palo Alto, CA; and Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA.
Insights
Racial and ethnic disparities in hypertension and chronic kidney disease (CKD) are influenced by social factors and emerging biological elements. Multidimensional treatment approaches are proposed for diverse US populations, including African Americans and Hispanics.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Public Health
Background:
- Persistent disparities in hypertension, chronic kidney disease (CKD), and cardiovascular disease exist among US racial/ethnic minority groups.
- While social determinants of health are primary mediators, emerging data suggest biological factors also contribute to these health disparities.
- Race is a social construct, and ethnicity definitions are imprecise, yet race/ethnicity categories aid in interpreting health data and ensuring clinical trial generalizability.
Purpose of the Study:
- To review hypertension epidemiology, pathophysiology, and management in diverse US minority populations, focusing on African Americans and Hispanics.
- To highlight the intersection of hypertension and CKD, particularly in African Americans.
- To propose multidimensional treatment strategies for hypertension in diverse populations.
Main Methods:
- Literature review exploring existing data on hypertension and CKD in US racial/ethnic minority groups.
- Analysis of the interplay between social determinants of health, potential biological factors, and health outcomes.
- Synthesis of current understanding and proposal of integrated treatment approaches.
Main Results:
- Hypertension and CKD disparities are significant, influenced by both social and biological factors.
- African Americans experience a high burden of hypertension and CKD, underscoring the need for targeted research and interventions.
- Heterogeneity exists within racial/ethnic groups, suggesting a need for nuanced approaches beyond broad categorizations.
Conclusions:
- Addressing hypertension and CKD disparities requires understanding the complex interplay of social, biological, and genetic factors.
- Multidimensional treatment strategies involving population, community, health system, and individual levels are essential for diverse populations.
- Further research is needed to elucidate biological mechanisms and refine interventions for specific minority groups.
Abstract:
Persistent disparities in hypertension, CKD, and associated cardiovascular disease have been noted in the United States among racial/ethnic minority groups. Overall, these disparities are largely mediated by social determinants of health. Yet, emerging data suggest additional biologic factors in racial/ethnic disparities in hypertension prevalence, complications, particularly CKD, and responses to treatment. Nevertheless, race is a social construct and not a physiologic concept, and ethnicity, federally defined as the binary "Hispanic/Latino" or "not Hispanic/Latino," is also imprecise. However, race/ethnicity categories may help interpret health-related data, including surveillance and research, and are important in ensuring that clinical trials remain generalizable to diverse populations. There is significant heterogeneity among prespecified groups and, perhaps, greater genetic differences within than between certain racial/ethnic groups. This review will explore hypertension epidemiology, pathophysiology, and management among the diverse and growing US minority groups, specifically African Americans and Hispanics because much less data are available across the wide spectrum of diverse populations. We will highlight the intersection of hypertension and increasingly prevalent CKD, particularly in African Americans. Finally, we propose multidimensional treatment approaches to hypertension among diverse populations, encompassing population, community, health system, and individual-based approaches.
Related Concept Videos
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Hypertension V: Nursing Management

